KAM

Krensavage Asset Management Portfolio holdings

AUM $189M
This Quarter Return
+4.01%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$282M
AUM Growth
+$282M
Cap. Flow
-$653K
Cap. Flow %
-0.23%
Top 10 Hldgs %
99.48%
Holding
16
New
4
Increased
3
Reduced
3
Closed
4

Top Buys

1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$12.3M
2
SNY icon
Sanofi
SNY
$7.48M
3
MASI icon
Masimo
MASI
$938K
4
MURA icon
Mural Oncology
MURA
$538K
5
ALKS icon
Alkermes
ALKS
$332K

Top Sells

1
EMBC icon
Embecta
EMBC
$17.5M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
$1.78M
3
VNDA icon
Vanda Pharmaceuticals
VNDA
$1.56M
4
CAH icon
Cardinal Health
CAH
$992K
5
KOD icon
Kodiak Sciences
KOD
$616K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EXEL icon
1
Exelixis
EXEL
$10.1B
$45.6M 16.16% 1,899,079 -72 -0% -$1.73K
UTHR icon
2
United Therapeutics
UTHR
$13.8B
$44.2M 15.67% 200,872 -350 -0.2% -$77K
BIIB icon
3
Biogen
BIIB
$19.4B
$41.5M 14.73% 160,480 – –
REGN icon
4
Regeneron Pharmaceuticals
REGN
$61.5B
$41.5M 14.73% 47,256 – –
CAH icon
5
Cardinal Health
CAH
$35.5B
$28.4M 10.07% 281,476 -9,843 -3% -$992K
TARO
6
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$27M 9.58% 646,453 +5,718 +0.9% +$239K
ALKS icon
7
Alkermes
ALKS
$4.78B
$25.5M 9.04% 918,038 +11,978 +1% +$332K
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$7.75B
$12.3M 4.36% +100,000 New +$12.3M
SNY icon
9
Sanofi
SNY
$121B
$7.48M 2.65% +150,400 New +$7.48M
ENTA icon
10
Enanta Pharmaceuticals
ENTA
$180M
$6.99M 2.48% 742,824 +7,721 +1% +$72.7K
MASI icon
11
Masimo
MASI
$7.59B
$938K 0.33% +8,000 New +$938K
MURA icon
12
Mural Oncology
MURA
$35.7M
$538K 0.19% +90,833 New +$538K
EGRX
13
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
– – -112,666 Closed -$1.78M
EMBC icon
14
Embecta
EMBC
$847M
– – -1,164,876 Closed -$17.5M
KOD icon
15
Kodiak Sciences
KOD
$478M
– – -342,312 Closed -$616K
VNDA icon
16
Vanda Pharmaceuticals
VNDA
$279M
– – -360,429 Closed -$1.56M